Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia.

@article{PedersenBjergaard2002GeneticPI,
  title={Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia.},
  author={J. Pedersen‐Bjergaard and M. Andersen and D. Christiansen and C. Nerlov},
  journal={Blood},
  year={2002},
  volume={99 6},
  pages={
          1909-12
        }
}
Therapy-related acute myeloid leukemia (t-AML) in most cases develops after chemotherapy of other malignancies and shows characteristic chromosome aberrations. Two general types of t-AML have previously been identified. One type is observed after therapy with alkylating agents and characteristically presents as therapy-related myelodysplasia with deletions or loss of the long arms of chromosomes 5 and 7 or loss of the whole chromosomes. The other type is observed after therapy with… Expand
Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.
Genetic Pathways Leading to Therapy-Related Myeloid Neoplasms
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 73 REFERENCES
Therapy-related acute promyelocytic leukemia: a report on 16 cases.
...
1
2
3
4
5
...